NASDAQ: MPLT
Maplight Therapeutics Inc Stock Ownership - Who owns Maplight Therapeutics?

Insider buying vs selling

Have Maplight Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Catalyst4 Inc10% Owner2025-10-285,441,176$17.00
$92.50MBuy
Holdings A. Novo10% Owner2025-10-28952,941$17.00
$16.20MBuy

1 of 1

MPLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MPLT insiders and whales buy or sell their stock.

MPLT Shareholders

What type of owners hold Maplight Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Catalyst4 Inc43.41%19,697,464$333.87MInsider
Holdings A. Novo8.13%3,686,622$62.49MInsider
Robert C. Malenka0.95%431,343$7.31MInsider
Christopher A. Kroeger0.73%330,778$5.61MInsider
Erin Pennock Foff0.11%48,275$818.26kInsider
Vishwas Setia0.10%43,367$735.07kInsider
Anatol Kreitzer0.08%35,953$609.40kInsider
James Woodruff Lillie0.07%32,539$551.54kInsider
Jonathan Gillis0.07%30,565$518.08kInsider
Kristopher Hanson0.06%27,098$459.31kInsider

1 of 2

MPLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MPLT0.00%53.72%Net BuyingNet Buying
PRME44.61%55.39%Net Buying
KALV58.99%41.01%Net BuyingNet Buying
VALN3.25%0.00%
ANNX78.53%21.47%Net BuyingNet Buying

Maplight Therapeutics Stock Ownership FAQ

Who owns Maplight Therapeutics?

Maplight Therapeutics (NASDAQ: MPLT) is owned by 0.00% institutional shareholders, 53.72% Maplight Therapeutics insiders, and 46.28% retail investors. Catalyst4 Inc is the largest individual Maplight Therapeutics shareholder, owning 19.70M shares representing 43.41% of the company. Catalyst4 Inc's Maplight Therapeutics shares are currently valued at $365.98M.

If you're new to stock investing, here's how to buy Maplight Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.